Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 123
10
Diseases
56
Unique genes
0.172
Avg. similarity score
Benign congenital myopathy
Most-connected disease (6 links)
Disease
Searched: progressive muscular dystrophy
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
progressive muscular dystrophy
Benign congenital myopathy
Dystrophinopathy
Leiomyosarcoma
Becker muscular dystrophy
Clinodactyly
Duchenne muscular dystrophy
Pseudo-torch syndrome
hereditary leiomyomatosis and renal cell cancer
thrombocytopenia-absent radius syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Benign congenital myopathy | 6 | 6 | 1 |
| Dystrophinopathy | 6 | 6 | 1 |
| Leiomyosarcoma | 6 | 6 | 7 |
| progressive muscular dystrophy | 6 | 6 | 1 |
| Becker muscular dystrophy | 4 | 4 | 3 |
| Clinodactyly | 4 | 4 | 18 |
| Duchenne muscular dystrophy | 3 | 3 | 29 |
| Pseudo-torch syndrome | 1 | 1 | 3 |
| hereditary leiomyomatosis and renal cell cancer | 1 | 1 | 1 |
| thrombocytopenia-absent radius syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| DMD | 7 / 10 | Becker muscular dystrophy, Benign congenital myopathy, Clinodactyly, Duchenne muscular dystrophy and 3 more |
| FH | 2 / 10 | hereditary leiomyomatosis and renal cell cancer, Leiomyosarcoma |
| RBM8A | 2 / 10 | Clinodactyly, thrombocytopenia-absent radius syndrome |
| USP18 | 2 / 10 | Leiomyosarcoma, Pseudo-torch syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Dilated cardiomyopathy | KEGG | 5 / 105 | 10.2× | 1.24e-4 | 2.70e-3 ✓ sig. |
| Regulation of IFNA signaling | Reactome | 3 / 24 | 26.8× | 1.81e-4 | 3.66e-3 ✓ sig. |
| Arrhythmogenic right ventricular cardiomyopathy | KEGG | 4 / 86 | 10.0× | 6.78e-4 | 1.03e-2 ✓ sig. |
| WNT mediated activation of DVL | Reactome | 2 / 9 | 47.7× | 7.53e-4 | 1.12e-2 ✓ sig. |
| Adenylate cyclase activating pathway | Reactome | 2 / 10 | 42.9× | 9.38e-4 | 1.33e-2 ✓ sig. |
| Ovarian steroidogenesis | KEGG | 3 / 52 | 12.4× | 1.81e-3 | 2.16e-2 ✓ sig. |
| Adenylate cyclase inhibitory pathway | Reactome | 2 / 14 | 30.6× | 1.87e-3 | 2.22e-2 ✓ sig. |
| Hedgehog 'off' state | Reactome | 3 / 56 | 11.5× | 2.23e-3 | 2.53e-2 ✓ sig. |
| Regulation of lipolysis in adipocytes | KEGG | 3 / 59 | 10.9× | 2.59e-3 | 2.83e-2 ✓ sig. |
| PKA activation in glucagon signalling | Reactome | 2 / 17 | 25.2× | 2.78e-3 | 2.97e-2 ✓ sig. |
| PKA activation | Reactome | 2 / 19 | 22.6× | 3.47e-3 | 3.46e-2 ✓ sig. |
| Long-term potentiation | KEGG | 3 / 67 | 9.6× | 3.72e-3 | 3.64e-2 ✓ sig. |
| SUMOylation of chromatin organization proteins | Reactome | 3 / 70 | 9.2× | 4.21e-3 | 3.96e-2 ✓ sig. |
| PTEN Loss of Function in Cancer | Reactome | 1 / 1 | 214× | 4.66e-3 | 4.24e-2 ✓ sig. |
| Biosynthesis of EPA-derived SPMs | Reactome | 1 / 1 | 214× | 4.66e-3 | 4.24e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| maintenance of blood-brain barrier | GO:0035633 | 3 / 34 | 29.4× | 1.43e-4 | 4.03e-3 ✓ sig. |
| regulation of heart rate | GO:0002027 | 3 / 39 | 25.7× | 2.16e-4 | 5.43e-3 ✓ sig. |
| positive regulation of CREB transcription factor activity | GO:0032793 | 2 / 10 | 66.7× | 3.91e-4 | 8.28e-3 ✓ sig. |
| cAMP biosynthetic process | GO:0006171 | 2 / 11 | 60.7× | 4.77e-4 | 9.48e-3 ✓ sig. |
| intracellular signal transduction | GO:0035556 | 7 / 471 | 5.0× | 4.93e-4 | 9.65e-3 ✓ sig. |
| regulation of cell differentiation | GO:0045595 | 3 / 54 | 18.5× | 5.67e-4 | 1.06e-2 ✓ sig. |
| neuroinflammatory response | GO:0150076 | 2 / 12 | 55.6× | 5.71e-4 | 1.07e-2 ✓ sig. |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 / 12 | 55.6× | 5.71e-4 | 1.07e-2 ✓ sig. |
| positive regulation of receptor recycling | GO:0001921 | 2 / 14 | 47.7× | 7.84e-4 | 1.32e-2 ✓ sig. |
| cellular response to forskolin | GO:1904322 | 2 / 16 | 41.7× | 1.03e-3 | 1.57e-2 ✓ sig. |
| regulation of sodium ion transmembrane transport | GO:1902305 | 2 / 16 | 41.7× | 1.03e-3 | 1.57e-2 ✓ sig. |
| ventricular cardiac muscle cell action potential | GO:0086005 | 2 / 17 | 39.3× | 1.17e-3 | 1.70e-2 ✓ sig. |
| cyclic nucleotide biosynthetic process | GO:0009190 | 2 / 18 | 37.1× | 1.31e-3 | 1.81e-2 ✓ sig. |
| positive regulation of synaptic transmission | GO:0050806 | 2 / 18 | 37.1× | 1.31e-3 | 1.81e-2 ✓ sig. |
| cellular response to glucose stimulus | GO:0071333 | 3 / 74 | 13.5× | 1.42e-3 | 1.90e-2 ✓ sig. |